{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:08Z","timestamp":1786119068724,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1097\/mph.0b013e31818a9564","type":"journal-article","created":{"date-parts":[[2009,1,8]],"date-time":"2009-01-08T03:13:47Z","timestamp":1231384427000},"page":"959-962","source":"Crossref","is-referenced-by-count":6,"title":["Refractory Nodular Lymphocyte Predominant Hodgkin Lymphoma Transformed to T-cell\/Histiocyte-rich B-cell Lymphoma in an Adolescent"],"prefix":"10.1097","volume":"30","author":[{"given":"Lucile","family":"Couronn\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Michel","family":"Picquenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Laberge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bastard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Pierre","family":"Vannier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-24-20210227","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1182\/blood-2003-02-0626","article-title":"Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell\/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell\/histiocyte-rich B-cell lymphoma","volume":"102","author":"Boudova","year":"2003","journal-title":"Blood"},{"key":"R2-24-20210227","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/13.S1.44","article-title":"Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell\/histiocyte-rich B cell lymphoma","volume":"13","author":"Rudiger","year":"2002","journal-title":"Ann Oncol"},{"key":"R3-24-20210227","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","article-title":"Soci\u00e9t\u00e9 Fran\u00e7aise d'Oncologie P\u00e9diatrique. The Soci\u00e9t\u00e9 Fran\u00e7aise d'Oncologie P\u00e9diatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia","volume":"97","author":"Patte","year":"2001","journal-title":"Blood"},{"key":"R4-24-20210227","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1634\/theoncologist.11-4-384","article-title":"T-cell\/histiocyte-rich B-cell lymphoma: biology, diagnosis, and management","volume":"11","author":"Abramson","year":"2006","journal-title":"Oncologist"},{"key":"R5-24-20210227","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1365-2559.2002.01466.x","article-title":"T-cell\/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma","volume":"41","author":"Fraga","year":"2002","journal-title":"Histopathology"},{"key":"R6-24-20210227","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/modpathol.3880035","article-title":"The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997","volume":"13","author":"Harris","year":"2000","journal-title":"Mod Pathol"},{"key":"R7-24-20210227","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","article-title":"Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation","volume":"27","author":"Fan","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R8-24-20210227","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"R9-24-20210227","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hon.773","article-title":"Therapeutic results in patients with relapsed diffuse large B cell Non-Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation","volume":"24","author":"Ferrara","year":"2006","journal-title":"Hematol Oncol"},{"key":"R10-24-20210227","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbmt.2003.09.015","article-title":"Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission","volume":"10","author":"Vose","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"R11-24-20210227","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2003-11-3911","article-title":"Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma","volume":"103","author":"Kewalramani","year":"2004","journal-title":"Blood"},{"key":"R12-24-20210227","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bbmt.2006.05.018","article-title":"Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma","volume":"12","author":"Aksentijevich","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"R13-24-20210227","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2141.2005.05755.x","article-title":"Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma","volume":"131","author":"Doocey","year":"2005","journal-title":"Br J Haematol"},{"key":"R14-24-20210227","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bmt.1703891","article-title":"European Bone Marrow Transplantation (EBMT) Lymphoma Registry. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation","volume":"31","author":"Peniket","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R15-24-20210227","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1182\/blood-2004-01-0231","article-title":"Lymphoma Working Committee of the International Bone Marrow Transplant Registry. Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry","volume":"104","author":"Freytes","year":"2004","journal-title":"Blood"},{"key":"R16-24-20210227","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.bmt.1700614","article-title":"Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma","volume":"19","author":"De Lima","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"R17-24-20210227","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.bmt.1704233","article-title":"Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphoma","volume":"32","author":"Seropian","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R18-24-20210227","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2004-03-1105","article-title":"Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma","volume":"104","author":"Morris","year":"2004","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e31818a9564","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:30:54Z","timestamp":1786037454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-200812000-00024"}},"subtitle":["Salvage Therapy With Allogeneic Bone Marrow Transplantation"],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e31818a9564","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}